Insider Trades of ORBIMED ADVISORS LLC Information

Click on the column header to resort ascending (▲) or descending (▼).

Individual Insider Trades

Company Relation Last Date Type Tran OwnerType Shares Traded Last Price Shares Held ▼
RELYPSA INC Beneficial Owner (10%) 11/20/2013 Form 4 Buy indirect 712,192 11 9,941,551
RELYPSA INC Beneficial Owner (10%) 11/20/2013 Form 4 Disposition (Non Open Market) indirect 27,282 11 8,907,342
RELYPSA INC Beneficial Owner (10%) 11/20/2013 Form 4 Acquisition (Non Open Market) indirect 7,511,930 0 7,511,930
RESPONSE BIOMEDICAL CORP Beneficial Owner (10%) 11/07/2013 Form 4 Buy indirect 816,325 2.45 3,047,927
INTERCEPT PHARMACEUTICALS INC Beneficial Owner (10%) 10/16/2012 Form 4 Buy indirect 333,334 15 2,150,634
INTERCEPT PHARMACEUTICALS INC Beneficial Owner (10%) 10/16/2012 Form 4 Acquisition (Non Open Market) indirect 1,817,300 0 1,817,300
INTERCEPT PHARMACEUTICALS INC Director 10/15/2013 Form 4 Sell indirect 376,585 62.5 1,775,347
INTERCEPT PHARMACEUTICALS INC Director 10/21/2013 Form 4 Sell indirect 40,088 62.5 1,735,259
INTERCEPT PHARMACEUTICALS INC Director 04/09/2014 Form 4 Sell indirect 81,305 320 1,654,603
ACCELERON PHARMA INC Other 09/24/2013 Form 4 Acquisition (Non Open Market) indirect 2,109,642 0 1,540,759
AMBIT BIOSCIENCES CORP Beneficial Owner (10%) 05/23/2013 Form 4 Buy indirect 12,500 6.9893 1,476,702
AMBIT BIOSCIENCES CORP Beneficial Owner (10%) 05/22/2013 Form 4 Buy indirect 21,300 6.861 1,464,322
AMBIT BIOSCIENCES CORP Beneficial Owner (10%) 05/21/2013 Form 4 Buy indirect 669,871 6.897 1,443,222
MIRATI THERAPEUTICS, INC. Beneficial Owner (10%) 10/29/2013 Form 4 Buy indirect 125,000 17.5 1,274,332
MIRATI THERAPEUTICS, INC. Beneficial Owner (10%) 06/27/2014 Form 4 Sell indirect 88,332 21.79 1,186,000
MIRATI THERAPEUTICS, INC. Beneficial Owner (10%) 06/30/2014 Form 4 Sell indirect 14,000 20.33 1,172,000
MIRATI THERAPEUTICS, INC. Beneficial Owner (10%) 07/01/2014 Form 4 Sell indirect 5,000 20.04 1,167,000
SUPERNUS PHARMACEUTICALS INC Beneficial Owner (10%) 02/12/2013 Form 4 Sell indirect 152,183 7.5218 858,100
SUPERNUS PHARMACEUTICALS INC Beneficial Owner (10%) 02/13/2013 Form 4 Sell indirect 150,000 7.5757 817,000
AMBIT BIOSCIENCES CORP Beneficial Owner (10%) 05/21/2013 Form 4 Acquisition (Non Open Market) indirect 776,189 0 779,674

Create your free portfolio